Roughly 20 to 22 analysts cover BILL, with a consensus near "Buy" and no Sell ratings. Aggregators place the average analyst price target near $60 to $61 (S&P Global data pegs it at roughly $60.9 across 22 analysts), with individual targets spanning from $50 (Mizuho) to $75 (Needham). Because that mean sits only about 4–5% above the current price — below a meaningful 10% threshold — this article uses $64 as the objective rather than presenting the average as a consensus target.
The $64 figure is genuinely discussed on the Street. Morgan Stanley (Equal-Weight) and UBS (Buy, new coverage) both set $64 on Nov. 11; TD Cowen lifted its target to $66 (Buy), while Citigroup, Oppenheimer, and Wolfe Research sit at $60 and KBW and Truist at $58. The cautious camp — Mizuho at $50 and Goldman Sachs at $53 — reflects concern that growth has slowed, while Needham's $75 represents the most bullish view. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With shares near $57.63, reaching $64 requires an advance of about 11% — a modest move by equity standards, though one that would take the stock decisively into record territory. The 52-week range is roughly $31.41 to $58.47, so the immediate challenge is clearing the prior high before testing the round-number zone around $60 and then $64.
The path runs through fundamentals. BILL delivered a strong fiscal fourth-quarter 2026 report in August with above-estimate fiscal 2027 guidance, and its most recent quarter showed a large operating-income beat even as revenue came in below some headline estimates. Core revenue growth in the low-double-digit to mid-teens range, combined with faster earnings growth, underpins the more constructive targets.
The $58.47 level marks the 52-week high and is the first meaningful resistance; a sustained close above it would establish a new breakout zone. Beyond that, the $60 round-number area (where several targets cluster) and then $64 become the next objectives. On the downside, support sits near $54, the site of recent consolidation, followed by $52–$53, where Goldman Sachs' target and prior resistance align.
Analyst price targets typically reflect a roughly 12-month research horizon, and the $64 objectives from Morgan Stanley and UBS carry that same forward-looking convention. Investors should monitor the next quarterly earnings release and updated fiscal 2027 guidance, any further analyst revisions, activist or strategic developments, small-business spending data, and interest-rate decisions from the Federal Reserve, which influence sentiment toward fintech names like BILL.
Reaching $64 would require BILL to extend about 11% from roughly $57.63 and push beyond its 52-week high — a modest percentage move, but one that hinges on sustained margin expansion and re-accelerating core revenue. The $64 objective rests on recent Street notes rather than a formal consensus, with the broader analyst range of $50 to $75 underscoring genuine disagreement about growth durability. The strongest supports are operating leverage, network scale, and positive analyst momentum; the main obstacles are slowing top-line growth, competition, and an already-elevated valuation. Investors should watch earnings, guidance, and strategic developments rather than treat any single price target as a guarantee.
In my own research process, Tickeron's AI Daily Buy/Sell Signals have proven useful for tracking names like this one that have moved sharply toward highs. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. It offers a practical way to stay on top of changing conditions without constant manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for BILL crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
BILL moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +19.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where BILL advanced for three days, in 237 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 164 of 223 cases where BILL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BILL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
BILL broke above its upper Bollinger Band on November 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.266) is normal, around the industry mean (-1.922). BILL's P/E Ratio (-476.455) is considerably lower than the industry average of (9.599). Projected Growth (PEG Ratio) (0.405) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (2.961) is also within normal values, averaging (70.699).
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. BILL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BILL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company, which engages in the provision of cloud-based software solutions and simplifies, digitizes, and automates complex back-office financial operations for SMBs.
Industry PackagedSoftware